The Anticancer Efficiency of Citrullus colocynthis Toward the Colorectal Cancer Therapy

被引:18
作者
Abdulridha, Manal Khalid [1 ]
Al-Marzoqi, Ali-H [2 ]
Ghasemian, Abdolmajid [3 ]
机构
[1] Mustansiriyah Univ, Dept Clin Pharm, Coll Pharm, Baghdad, Iraq
[2] Univ Babylon, Dept Biol, Coll Sci Women, Hillah, Iraq
[3] Islamic Azad Univ, Dept Biol, Cent Tehran Branch, Tehran, Iran
关键词
Colorectal cancer; Citrus colocynthis; Antioxidants; Herbal medicine; Anticancer therapy; C-PHYCOCYANIN; SCHRAD; FAMILY;
D O I
10.1007/s12029-019-00299-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Colorectal cancer (CRC) remains a major cause of death worldwide. Chemotherapy is associated with some side effects during CRC treatment. Hence, proper employment of lower toxic and approaches exerting lowest side effects are essential. The Citrullus colocynthis (C. colocynthis) seems a potential anticancerous herbal medicine (HM) against CRC mostly via various efficient compounds. Methods We performed a literature review regarding the anticancer traits of C. colocynthis against CRC. The possible active compounds, mechanisms, and combination therapies in vitro and in vivo or clinical trials have been also stated where found. Results and Conclusion The anticancerous effects of C. colocynthis has been via a variety of pathways including apoptotic pathways (increase in caspase-3 and inhibiting STAT3 function), antioxidant and anti-inflammatory (TNF-alpha, nitric oxide, and pro-inflammatory cytokines such as IL-6, IL-8, and IL-1 alpha) traits, inhibition of Wnt/beta-catenin signaling pathway, and antiangiogenesis and antimetastatic effects. Future studies will be promising regarding proper application of C. colocynthis compounds following their extraction.
引用
收藏
页码:439 / 444
页数:6
相关论文
共 32 条
[1]  
Adedosu OT, 2016, J CANC SCI THER, V8
[2]  
Akhzari M, 2015, J MOL BIOL, V4, P4, DOI [10.4172/2168- 9547.1000147, DOI 10.4172/2168-9547.1000147, 10.4172/2168-9547.1000147]
[3]  
[Anonymous], 2013, INT J MED AROMA PLAN
[4]  
[Anonymous], 2013, J MICROSCOPY ULTRAST
[5]  
Ataee N, 2011, J ARAK U MED SCI, V14, P82
[6]   Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases [J].
Benoist, S ;
Pautrat, K ;
Mitry, E ;
Rougier, P ;
Penna, C ;
Nordlinger, B .
BRITISH JOURNAL OF SURGERY, 2005, 92 (09) :1155-1160
[7]  
Campbell CE, 1998, INT J CANCER, V78, P182, DOI 10.1002/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.3.CO
[8]  
2-D
[9]  
Deming D, 2017, GUT, V67, P1095
[10]   Joint effects of family history and adult life dietary risk factors on colorectal cancer risk [J].
Fernandez, E ;
La Vecchia, C ;
Talamini, R ;
Negri, E .
EPIDEMIOLOGY, 2002, 13 (03) :360-363